Advanced Biomed (NASDAQ:ADVB) Shares Down 0.4% – Here’s Why

Shares of Advanced Biomed Inc. (NASDAQ:ADVB) traded down 0.4% on Monday . The company traded as low as $5.29 and last traded at $5.43. 33,202 shares were traded during trading, a decline of 92% from the average session volume of 421,917 shares. The stock had previously closed at $5.45.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings assumed coverage on shares of Advanced Biomed in a research report on Monday, January 26th. They issued a “sell (e+)” rating for the company. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Advanced Biomed presently has a consensus rating of “Sell”.

Advanced Biomed Stock Down 0.4%

The company has a market cap of $7.38 million and a PE ratio of 1.43.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.